Imidazopyrazine as tyrosine kinase inhibitors

Details for Australian Patent Application No. 2005267120 (hide)

Owner OSI Pharmaceuticals, Inc.

Inventors Crew, Andrew Philip; Werner, Douglas Scott; Mulvihill, Mark Joseph

Agent Spruson & Ferguson

Pub. Number AU-B-2005267120

PCT Pub. Number WO2006/012422

Priority 60/589,514 20.07.04 US

Filing date 20 July 2005

Wipo publication date 2 February 2006

Acceptance publication date 2 June 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/012422 Priority application(s): WO2006/012422

2 June 2011 Application Accepted

  Published as AU-B-2005267120

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267121-Therapy programming guidance based on stored programming history

2005267119-Steerable catheter with hydraulic or pneumatic actuator